Article
Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Nov 2019
Liu Zhuo, Kong Jiangyin, Kong Yuanyuan, Cai Feng, Xu Xiaocheng, Liu Jun, Wang Shihua
Abstract excerpt
BACKGROUND: Identification of biomarkers predicting a response to chemotherapeutic drugs would greatly ease the selection of personalized therapy. The protein xeroderma pigmentosum group D (XPD) functions in nucleotide excision repair (NER) to remove DNA cross-links and in the regulation of transcription. The potential role of the Asp312Asn polymorphism in predicting the response to chemotherapy has not been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
